Biotech article - September 10, 2014
Danish biotech company among top SMEs
The European Association for Bioindustries has announced the top five biotech SMEs in Europe and Danish Biosyntia is among the five contenders. Biosyntia and the other four companies will compete to win the award as the ‘Most Innovative EU Biotech SME’. The other contenders are UK-based healthcare biotech company, Autifony; the Italian industrial biotech company, Bio-on; the French […]
Biotech article - March 31, 2014
No preliminary investigation on Active Biotech
In the end of February Active Biotech was reported to the Swedish Economic Crime Authority, which has now decided not to precede with a preliminary investigation. The complaint to the Swedish Economic Crime Authority came from the organization INDEIN (Investigation Development for Investors). As reported in the web edition of the Swedish newspaper Sydsvenskan Active Biotech […]
Biotech article - February 27, 2014
Active Biotech reported for economic crime
The Lund-based pharmaceutical company has been reported to the Swedish Economic Crime Authority. Active Biotech is accused to have to misinformed their investors. Allegedly, the firm was aware of the that the MS drug Nerventra should have been stopped but concealed it. On January 25, the company share went down dramatically on the stock market. […]
Biotech article - February 4, 2014
Norway invests in biotech
The Research Council of Norway has allocated NOK 454 million in funding over four years to projects in the ICT sector, biotechnology and biomedicine. In total, 58 companies were awarded funding, and over one third of these were first-time applicants for Research Council funding. “It is a very good sign that we have received so many excellent […]
Biotech article - January 23, 2014
Pharmbiotech Oy to launch biomass production
Russian Biopharmos’ Finnish subsidiary will start biomass production in Finland. The ambition is to initiate biomass production for the medical and food industries in Hamina, south-eastern Finland, by the end of 2014. The project investment is estimated at EUR 2 million. Installation of equipment at the plant located near the Port of Hamina could start in March, […]
Biotech article - May 16, 2013
Blue biotechnology wave
Nordic researchers are exploring bioactive compounds from the sea, looking for anticancer drugs, antibiotics, and more. The Baltic and North Seas contain more than great herring. The oceans also hold a wealth of biotechnology resources. So far, nine marine-inspired drugs such as the breast cancer therapy Halaven, have been approved in the United States or […]
